Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLIS-1: PF-08653945 and PF-08653944 in Overweight or Obesity
NCT07575932Phase 2Active, not recruiting
- Sponsor
- Pfizer
- Start
- May 2026
- Primary completion
- Aug 2027
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of PF-08653945, PF-08653944 in obesity, sponsored by Pfizer. Started May 2026; status: active, not recruiting.
02
Drugs
PF-08653945PF-08653944
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07575932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07575932.